Recombinant Human MGLL Protein，His

The study of the MGLL (Monoacylglycerol Lipase) recombinant protein has garnered significant attention due to its crucial role in lipid metabolism and potential implications in various pathologies, including obesity, diabetes, and neurodegenerative diseases. MGLL is a serine hydrolase responsible for the hydrolysis of monoacylglycerols into glycerol and free fatty acids, thus regulating endocannabinoid signaling pathways and energy homeostasis. This enzyme's activity influences numerous physiological processes, including pain perception and appetite regulation. Given the increasing prevalence of metabolic disorders and the complexity of endocannabinoid system interactions, researchers are focusing on the structural and functional characterization of MGLL to better understand its mechanisms and therapeutic potential. The generation of recombinant MGLL allows for detailed biochemical analyses, substrate specificity assessments, and the exploration of potential inhibitors, which could pave the way for novel therapeutics targeting MGLL-related pathways. Improvements in recombinant protein expression systems have enabled the production of MGLL in adequate quantities for high-resolution crystallography and functional assays, facilitating insights into its catalytic mechanism and regulatory interactions. Consequently, a comprehensive understanding of MGLL's role in health and disease could lead to innovative treatment strategies to manage conditions associated with dysregulated lipid metabolism and cannabinoid signaling.